Confluent and reticulated papillomatosis

Author: Vanessa Ngan, Staff Writer, 2005.

What is confluent and reticulated papillomatosis?

CRP is a rare skin disease characterised by a network pattern of discoloured small flat plaques. It mainly affects the mid trunk of young adults.

Confluent and reticulated papillomatosis is also known as Gougerot-Carteaud Syndrome. Gourgerot and Carteaud originally described the condition in 1927.

Who gets confluent and reticulated papillomatosis

Confluent and reticulated papillomatosis is more common in young women than in men (except in Japan where the reverse is true) and usually starts soon after puberty

What is the cause of confluent and reticulated papillomatosis?

The cause of confluent and reticulated papillomatosis is unknown. Several possible causes have been suggested and include:

What are the clinical features of confluent and reticulated papillomatosis?

Confluent and reticulated papillomatosis causes no symptoms.  Characteristics are:

Confluent and reticulated papillomatosis is chronic with exacerbations and remissions. In some cases, after spreading slowly for a few years, the lesions remain permanently unchanged.

What is the treatment for confluent and reticulated papillomatosis?

Confluent and reticulated papillomatosis is a benign skin disorder that results in cosmetic disfigurement. Several therapies have been used in an attempt to clear the condition and prevent it from recurring but response is inconsistent. Weight loss has been advocated in those that are overweight.

Antimicrobial agents

Medication that regulates cell development and prevents skin cell growth 

Discontinuation of successful treatment may result in a recurrence of the condition.

Related information

Email Newsletter

Would you like to receive our dermatology updates by email?


Submit your images

We're seeking high-quality photos of skin diseases.  


Machine diagnosis

Watch DermNet's proposal to create a 'Skin Disease Image Recognition Tool' - winner of the 2017 'Clinicians' Challenge Active Award' by the NZ Ministry of Health and HiNZ.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter